Home >> Chemicals Listing >> hot product list by E  

Ethanedioic acid,potassium salt (1:1) (127-95-7)

Identification
Name:Ethanedioic acid,potassium salt (1:1)
Synonyms:Essential salt of lemon;Oxalic acid, monopotassium salt;Potassium hydrogen oxalate;Potassium oxalate (KHC2O4);Monopotassium oxalate;
CAS:127-95-7
EINECS: 204-873-0
Molecular Formula: C2HKO4
Molecular Weight: 128.12524
InChI: InChI=1S/C2H2O4.K/c3-1(4)2(5)6;/h(H,3,4)(H,5,6);/q;+1/p-1
Molecular Structure: (C2HKO4) Essential salt of lemon;Oxalic acid, monopotassium salt;Potassium hydrogen oxalate;Potassium oxalate...
Properties
Transport:2811
Melting Point: Decomposes
Density:g/cm3
Stability:Stable.
Water Solubility:appreciable Stability Stable. Toxicology Harmful if swallowed. Respiratory, eye and skin irritant. Toxicity data (The meaning of any toxicological abbreviations
Solubility:appreciable

Appearance:white crystalline powder
Specification:

The IUPAC name of Potassium binoxalate is potassium 2-hydroxy-2-oxoacetate. With the CAS registry number 127-95-7, it is also named as Oxalic acid, monopotassium salt. The product's classification code is Human Data. Besides, it is white crystalline powder, which is generally soluble in water. And below 50 °C, this chemical reacts to form the much less soluble potassium tetraoxalate, which separates out.

The other characteristics of this product can be summarized as: (1)EINECS: 204-873-0; (2)ACD/LogP: -1.19; (3)# of Rule of 5 Violations: 0; (4)ACD/LogD (pH 5.5): -5.7; (5)ACD/LogD (pH 7.4): -5.94; (6)ACD/BCF (pH 5.5): 1; (7)ACD/BCF (pH 7.4): 1; (8)ACD/KOC (pH 5.5): 1; (9)ACD/KOC (pH 7.4): 1; (10)H bond acceptors: 4; (11)H bond donors: 2; (12)Freely Rotating Bonds: 1; (13)Polar Surface Area: 63.6 Å2; (14)Density: 2.0 g/mL at 25 °C; (15)Flash Point: 188.8 °C; (16)Enthalpy of Vaporization: 67.15 kJ/mol; (17)Boiling Point: 365.1 °C at 760 mmHg; (18)Vapour Pressure: 2.51E-06 mmHg at 25 °C.

Preparation of Potassium binoxalate: Please dissolve 12.6 g Oxalic acid dihydrate in 300mL water. And please dissolve 18.4 g Potassium oxalate monohydrate in 100mL water. Then you should add aqueous solution of potassium oxalate to aqueous solution of Oxalic acid at 3 °C. After that, please place it at 0 °C for 24h. Finally, separate it out.

When you are using this chemical, please be cautious about it as the following: inhalation of its dust may cause irritation of nose and throat. And ingestion it may cause burning pain in throat, esophagus, and stomach. In addition, the exposed areas of mucous membrane would turn white, vomiting, severe purging, weak pulse, and cardiovascular collapse. It may cause mild irritation of skin and eyes if contact with dust.

People can use the following data to convert to the molecule structure.
(1)SMILES:[K+].[O-]C(=O)C(=O)O
(2)InChI:InChI=1/C2H2O4.K/c3-1(4)2(5)6;/h(H,3,4)(H,5,6);/q;+1/p-1
(3)InChIKey:JMTCDHVHZSGGJA-REWHXWOFAF
(4)Std. InChI:InChI=1S/C2H2O4.K/c3-1(4)2(5)6;/h(H,3,4)(H,5,6);/q;+1/p-1
(5)Std. InChIKey:JMTCDHVHZSGGJA-UHFFFAOYSA-M

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man TDLo intravenous 1071mg/kg (1071mg/kg) BEHAVIORAL: GENERAL ANESTHETIC

GASTROINTESTINAL: CHANGE IN STRUCTURE OR FUNCTION OF ESOPHAGUS

GASTROINTESTINAL: NAUSEA OR VOMITING
Medecine Legale et Dommage Corporel. Vol. 4, Pg. 178, 1971.
women LDLo oral 660mg/kg (660mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION
Muenchener Medicinische Wochenschrift. Vol. 79, Pg. 1481, 1932.
women TDLo oral 100mg/kg (100mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED
Muenchener Medicinische Wochenschrift. Vol. 79, Pg. 1481, 1932.
women TDLo oral 400mg/kg (400mg/kg) BEHAVIORAL: FLUID INTAKE

VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION

GASTROINTESTINAL: NAUSEA OR VOMITING
Muenchener Medicinische Wochenschrift. Vol. 79, Pg. 1481, 1932.

Report:

The IUPAC name of Potassium binoxalate is potassium 2-hydroxy-2-oxoacetate. With the CAS registry number 127-95-7, it is also named as Oxalic acid, monopotassium salt. The product's classification code is Human Data. Besides, it is white crystalline powder, which is generally soluble in water. And below 50 °C, this chemical reacts to form the much less soluble potassium tetraoxalate, which separates out.

The other characteristics of this product can be summarized as: (1)EINECS: 204-873-0; (2)ACD/LogP: -1.19; (3)# of Rule of 5 Violations: 0; (4)ACD/LogD (pH 5.5): -5.7; (5)ACD/LogD (pH 7.4): -5.94; (6)ACD/BCF (pH 5.5): 1; (7)ACD/BCF (pH 7.4): 1; (8)ACD/KOC (pH 5.5): 1; (9)ACD/KOC (pH 7.4): 1; (10)H bond acceptors: 4; (11)H bond donors: 2; (12)Freely Rotating Bonds: 1; (13)Polar Surface Area: 63.6 Å2; (14)Density: 2.0 g/mL at 25 °C; (15)Flash Point: 188.8 °C; (16)Enthalpy of Vaporization: 67.15 kJ/mol; (17)Boiling Point: 365.1 °C at 760 mmHg; (18)Vapour Pressure: 2.51E-06 mmHg at 25 °C.

Preparation of Potassium binoxalate: Please dissolve 12.6 g Oxalic acid dihydrate in 300mL water. And please dissolve 18.4 g Potassium oxalate monohydrate in 100mL water. Then you should add aqueous solution of potassium oxalate to aqueous solution of Oxalic acid at 3 °C. After that, please place it at 0 °C for 24h. Finally, separate it out.

When you are using this chemical, please be cautious about it as the following: inhalation of its dust may cause irritation of nose and throat. And ingestion it may cause burning pain in throat, esophagus, and stomach. In addition, the exposed areas of mucous membrane would turn white, vomiting, severe purging, weak pulse, and cardiovascular collapse. It may cause mild irritation of skin and eyes if contact with dust.

People can use the following data to convert to the molecule structure.
(1)SMILES:[K+].[O-]C(=O)C(=O)O
(2)InChI:InChI=1/C2H2O4.K/c3-1(4)2(5)6;/h(H,3,4)(H,5,6);/q;+1/p-1
(3)InChIKey:JMTCDHVHZSGGJA-REWHXWOFAF
(4)Std. InChI:InChI=1S/C2H2O4.K/c3-1(4)2(5)6;/h(H,3,4)(H,5,6);/q;+1/p-1
(5)Std. InChIKey:JMTCDHVHZSGGJA-UHFFFAOYSA-M

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man TDLo intravenous 1071mg/kg (1071mg/kg) BEHAVIORAL: GENERAL ANESTHETIC

GASTROINTESTINAL: CHANGE IN STRUCTURE OR FUNCTION OF ESOPHAGUS

GASTROINTESTINAL: NAUSEA OR VOMITING
Medecine Legale et Dommage Corporel. Vol. 4, Pg. 178, 1971.
women LDLo oral 660mg/kg (660mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION
Muenchener Medicinische Wochenschrift. Vol. 79, Pg. 1481, 1932.
women TDLo oral 100mg/kg (100mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED
Muenchener Medicinische Wochenschrift. Vol. 79, Pg. 1481, 1932.
women TDLo oral 400mg/kg (400mg/kg) BEHAVIORAL: FLUID INTAKE

VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION

GASTROINTESTINAL: NAUSEA OR VOMITING
Muenchener Medicinische Wochenschrift. Vol. 79, Pg. 1481, 1932.

Packinggroup: III
Color: Monoclinic, colorless crystals
Safety Data